It is the same message. The vaccine without the adjuvant is preferable because we have less data about the vaccine with the adjuvant during pregnancy. This is an option for women. This week and last week, the recommendation was the same, i.e. less than 20 weeks. The risk for pregnant women is the same as for other women of the same age group. However, after 20 weeks of pregnancy, the risks go up almost four-fold. If the illness is present in the community, the risk is greater than the theoretical risk of the vaccine.
On October 26th, 2009. See this statement in context.